Session Track · IDC 2027

Genodermatoses at IDC 2027

Part of the IDC 2027 scientific programme · NH Villa Carpegna, Rome, Italy · June 21–23, 2027

About the Genodermatoses Session

Genodermatoses refer to a group of genetic skin diseases. These genetic skin conditions can have a variety of clinical presentations and vary in terms of severity, management, and prognosis. Although the exact prevalence of genodermatoses is unknown, some estimates suggest that up to 6-8% of all dermatologic visits are related to genetic skin disorders. Genodermatoses can be inherited in either an autosomal recessive, autosomal dominant, or X-linked manner. Autosomal recessive inheritance means that a mutation must be present in each of the two gene copies (one on each chromosome) to cause the disorder. Autosomal dominant inheritance is when only a single gene copy must carry the mutation, and X-linked inheritance is when an affected male typically passes the disorder on to their sons, while only an affected female may pass it on to her children. Diagnosis of these genetic skin conditions often relies on the various characteristic signs and symptoms, family history, and genetic testing. There is no single, straightforward test that can definitively diagnose all types of genodermatoses. In some cases, genetic testing can be used to identify the type of mutation present and thus confirm the diagnosis; however, this is not always possible or necessary. Treatment of these genetic skin diseases is often complex and depends on the specific disorder and its severity. Depending on the disorder, treatment may involve the use of medication, course of antibiotics, topical medications, laser treatments, or other modalities. Genetic counseling is often recommended for individuals with a family history of any type of genodermatoses. This is especially true in cases of autosomal dominant or X-linked genodermatoses, as genetic testing is more reliable in these cases than in cases of autosomal recessive disorders. Genetic counseling can provide individuals and family members with information on the disorder and potential preventive measures to avoid passing on the disorder to their future generations. In conclusion, genodermatoses are a wide array of genetic skin conditions that often require complex and individualized management. Although not all cases can be definitively diagnosed with genetic testing, finding the correct diagnosis is paramount to ensure appropriate treatment and preventative measures for the family.

Featured Speakers — Genodermatoses 2027

Speaker lineup for this track will be announced soon.

Browse all speakers →

Recent Research Presented at Genodermatoses Sessions

Selected abstracts from this track will be published here.

Related Scientific Sessions at IDC 2027

Why Attend the Genodermatoses Conference 2027

Earn CPD Credit

Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.

Present Your Research

Oral and poster slots for original Genodermatoses work, reviewed by the scientific committee.

Network Globally

Meet researchers, clinicians, and industry leaders from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Genodermatoses research and practice.

Hybrid Flexibility

Attend in person in Rome or join virtually — same programme, same certificate.

Join IDC 2027 for the Genodermatoses track

Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.

Genodermatoses Conference 2027 — FAQs

What is the Genodermatoses track at IDC 2027?

The Genodermatoses track is a dedicated stream within IDC 2027 covering the latest research, clinical innovation, and best practice in Genodermatoses. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Genodermatoses sessions?

Researchers, clinicians, educators, doctoral students, and industry leaders with an interest in Genodermatoses are all welcome — whether presenting or attending.

Can I present my research in the Genodermatoses track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Genodermatoses sessions?

Yes. IDC 2027 is a hybrid conference — attend the Genodermatoses track in person in Rome or join live online, with on-demand access afterward.

Join the IDC 2027 delegation

Rome · June 21–23, 2027 · Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.